Werewolf Therapeutics appoints Anil Singhal to board of directors

Werewolf Therapeutics (HOWL), announced the appointment of Anil Singhal, Ph.D., President and CEO of Trishula Therapeutics, as a member of its board of directors. Concurrent with the appointment of Dr. Singhal, Werewolf announced that Derek DiRocco plans to resign as a director of the Company, effective as of the Company’s 2025 annual meeting of stockholders.